Impact of clinical input variable uncertainties on ten-year atherosclerotic cardiovascular disease risk using new

Himanshu Gupta1,2, Chun G Schiros3, Oleg F Sharifov3

  • 1Department of Medicine, Cardiovascular Disease, University of Alabama at Birmingham, 1808 7th Ave South, BDB 101, Birmingham, AL, 35294, USA. hgupta@uab.edu.

Insights

Clinical variable uncertainties can change atherosclerotic cardiovascular risk estimates. Healthcare providers should discuss these variations and improve measurement accuracy for better patient care under new guidelines.

Area of Science:

  • Cardiology
  • Public Health
  • Biostatistics

Background:

  • The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend Pooled Cohort equations for atherosclerotic cardiovascular risk assessment.
  • The influence of uncertainties in clinical input variables on these ten-year cardiovascular risk estimates remains unexamined.

Purpose of the Study:

  • To quantify the impact of clinical input variable uncertainties on ten-year atherosclerotic cardiovascular risk estimates.
  • To analyze how variations in age, cholesterol levels, and blood pressure affect risk categorization based on ACC/AHA guidelines.

Main Methods:

  • Utilized the National Health and Nutrition Examination Survey dataset (2005-2010).
  • Calculated maximum and minimum ten-year cardiovascular risks by introducing clinically relevant variations in age, total cholesterol, HDL cholesterol, and systolic blood pressure.
  • Assessed changes in risk category at 5% and 7.5% risk limits, which guide drug therapy decisions.

Main Results:

  • Up to 24% of the population cohort experienced a change in risk category due to input variable uncertainties at both 5% and 7.5% risk thresholds.
  • This effect was consistent across subgroups, with African American males showing a high baseline risk irrespective of variable variations.

Conclusions:

  • Uncertainties in clinical variables significantly impact atherosclerotic cardiovascular risk categorization.
  • Accurate measurement of clinical variables and standardized laboratory parameters are crucial for implementing ACC/AHA guidelines effectively.
  • Future risk calculators should allow customization to accommodate individual patient circumstances.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
519
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
562
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
697
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.4K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
938